Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8209126 | Applied Radiation and Isotopes | 2016 | 8 Pages |
Abstract
99mTc-tricarbonyl-vardenafil was specifically radiosynthesized for diagnostic evaluation of erectile dysfunction with a radiochemical yield ~97.2%. It was stable in saline up to 15Â h and in serum for more than 6Â h. The radiocomplex was lipophilic with a partition coefficient ~1.32 and plasma protein binding 72-76%. Its structure was determined using molecular mechanics and confirmed by NMR. In-silico docking to its target PDE5 enzyme was performed. The radiocomplex inhibitory activity was assessed and its IC50 was 0.7Â nM. Biodistribution in normal rats and biological evaluation in rat models of erectile dysfunction were performed. The results strongly suggested that 99mTc-tricarbonyl-vardenafil is a good candidate to image erectile dysfunction in humans.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
O.A. El-Kawy, J.A. GarcÃa-Horsman, R.K. Tuominen,